How obesity affects daily activities and physical abilities in older adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares physical abilities, body composition, and motor-skill performance between obese elderly adults and normal-weight elderly adults. Participants include individuals over 65 with BMI over 35 kg/m2 undergoing a 3-week metabolic rehabilitation program, and age- and sex-matched normal-weight controls with BMI 20-25 kg/m2 living independently. Assessments involve fitness tests and questionnaires to understand how excess adipose tissue and aging affect daily living activities. The goal is to see which factors most influence daily function in sarcopenic obesity and related conditions. No interventional treatments are tested beyond standard care and assessment tools.

Why it matters

Who can join: the full rules

Obese elderly:

Inclusion Criteria:

* Both sexes
* Body Mass Index \> 35 kg/m2
* Age \> 65 years
* Hospitalized for a 3-week integrated metabolic rehabilitation program

Exclusion Criteria:

* Absence of signed informed consent

Normal weight elderly:

Inclusion Criteria:

* Both sexes
* Body Mass Index 20-25 kg/m2
* Age \> 65 years
* Attendance of healthy lifestyle program in their home town

Exclusion Criteria:

* Absence of signed informed consent

Where it's running

• Istituto Auxologico Italiano IRCCS, Site Piancavallo
  Oggebbio, Italy Recruiting

Study contacts

• Study coordinator: Alessandro Sartorio, MD
• Email: sartorio@auxologico.it
• Phone: +3902619111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GLP-1 drug effects on muscle and bone during weight loss

  It tests whether GLP-1–based weight-loss medication (tirzepatide) plus a lifestyle program changes muscle and bone in adults 18–50 with obesity (BMI 30–40).

  Recruiting Phase 4 Pennington Biomedical Research Center · Baton Rouge, Louisiana and 1 other locations · NCT07154719

• Understanding the human metagenome's role in metabolic diseases

  This study is trying to see how the bacteria and substances in our bodies relate to health and conditions like obesity and muscle loss by looking at samples from different people.

  Recruiting Sengkang General Hospital · Singapore · NCT06363253

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.